Progress in the delivery of nanoparticle constructs: towards clinical translation
Files in This Item:
|COPHAR_D14-00045_revised_22092015.docx||81.56 kB||Microsoft Word||Download|
|Title:||Progress in the delivery of nanoparticle constructs: towards clinical translation||Authors:||Ryan, Sinéad M.
Brayden, David James
|Permanent link:||http://hdl.handle.net/10197/7236||Date:||Oct-2014||Online since:||2015-11-23T12:42:02Z||Abstract:||The application of nanoparticle constructs in drug delivery and nanomedicine is anticipated to have a great impact on future public health. Progress in this area is expected to address some of modern medicine's unresolved problems and recent literature contains many articles discussing this topic. We focus here on recent nanomedicine developments mainly in relation to cancer, which have either being approved for the market or clinical trials. We review nanomedicines in clinical use, nano-construct delivery systems (both non-targeted and targeted), imaging agents, as well as theranostics.||Funding Details:||Department of Agriculture, Food and the Marine
European Commission - Seventh Framework Programme (FP7)
|Type of material:||Journal Article||Publisher:||Elsevier||Journal:||Current Opinion in Pharmacology||Volume:||18||Start page:||120||End page:||128||Copyright (published version):||2014 Elsevier||Keywords:||Nanomedicine; Cancer; Theranostics; Targeted and clinical nanoparticles||DOI:||10.1016/j.coph.2014.09.019||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Veterinary Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.